# US (CO): Cannabis company to close Denver grow facility, cut 132 jobs > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-industry-consolidation-impacts-denver-grow-facility/ > **Published:** 2026-03-23T15:03:09-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:41:29-04:00 > **Clinical Summary:** Explore cannabis industry consolidation impacts on Denver grow facility closures and patient access to medical cannabis products. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Market AccessSupply ChainIndustry Policy[Patient Care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/)[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) Why This Matters [Cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) consolidation and facility closures can disrupt [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) to consistent products, particularly problematic for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients who rely on specific cultivars or formulations for symptom management. Supply chain instability may force patients to switch products, potentially compromising therapeutic outcomes. Clinical Summary A Colorado cannabis company is closing its Denver cultivation facility and eliminating 132 jobs, reflecting broader industry consolidation pressures in mature cannabis markets. While specific company details weren’t provided, such closures typically result from oversupply, regulatory costs, and market competition. For medical patients, facility closures can create supply disruptions for specific products they depend on for consistent therapeutic effects. Dr. Caplan’s Take “I see this pattern across mature markets — industry consolidation often prioritizes profit margins over patient needs. My concern is always continuity of care when patients lose access to products that work for them.” Clinical Perspective 🧠 Clinicians should prepare patients for potential product availability changes and discuss backup therapeutic options. Patients using specific cultivars or products should consider identifying alternative sources or similar formulations before supply disruptions occur. This underscores the importance of focusing on consistent cannabinoid profiles rather than brand loyalty. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20US%20%28CO%29%3A%20Cannabis%20company%20to%20close%20Denver%20grow%20facility%2C%20cut%20132%20jobs%20%40drcaplan&url=https%3A//www.mmjdaily.com/article/9822203/us-co-cannabis-company-to-close-denver-grow-facility-cut-132-jobs/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.mmjdaily.com/article/9822203/us-co-cannabis-company-to-close-denver-grow-facility-cut-132-jobs/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20US%20%28CO%29%3A%20Cannabis%20company%20to%20close%20Denver%20grow%20facility%2C%20cut%20132%20jobs%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.mmjdaily.com/article/9822203/us-co-cannabis-company-to-close-denver-grow-facility-cut-132-jobs/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.mmjdaily.com/article/9822203/us-co-cannabis-company-to-close-denver-grow-facility-cut-132-jobs/](https://www.mmjdaily.com/article/9822203/us-co-cannabis-company-to-close-denver-grow-facility-cut-132-jobs/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What topics does this cannabis news article cover?](#What_topics_does_this_cannabis_news_article_cover) - [Why is this news considered to have clinical relevance?](#Why_is_this_news_considered_to_have_clinical_relevance) - [What does “Notable Clinical Interest” mean for healthcare providers?](#What_does_8220Notable_Clinical_Interest8221_mean_for_healthcare_providers) - [How does this news relate to patient care?](#How_does_this_news_relate_to_patient_care) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, which indicates “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare providers should monitor closely. #### What topics does this cannabis news article cover? The article covers four key areas: Market Access, Supply Chain, Industry Policy, and [Patient Care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). These topics indicate the news relates to both regulatory/business aspects and direct patient impact in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). #### Why is this news considered to have clinical relevance? The CED Clinical Relevance system identifies content with potential impact on medical practice. A rating of #70 suggests this news contains developments that could influence how healthcare providers approach cannabis-related patient care or policy decisions. #### What does “Notable Clinical Interest” mean for healthcare providers? This designation indicates the content contains emerging findings or policy developments worth monitoring closely. Healthcare providers should be aware of these developments as they may impact future cannabis treatment protocols or [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/). #### How does this news relate to patient care? The article is tagged with “Patient Care” among its key topics, suggesting it contains information that could directly or indirectly affect cannabis patients. This may include changes in access, supply chain improvements, or policy modifications that impact treatment availability. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “US (CO): Cannabis company to close Denver grow facility, cut 132 jobs”, “url”: “https://www.mmjdaily.com/article/9822203/us-co-cannabis-company-to-close-denver-grow-facility-cut-132-jobs/”, “datePublished”: “2026-03-23T13:47:24Z”, “about”: “us co cannabis company close denver”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis company to close Denver grow facility, cut 132 jobs – The Business Journals](https://cedclinic.com/cannabis-industry-consolidation-impact-patient-access/) Detailed business coverage on the Denver cannabis grow facility closure and its workforce impact. [Read the full article](https://cedclinic.com/cannabis-industry-consolidation-impact-patient-access/) [PharmaCann closing Denver cannabis grow facility, laying off 132 – The Denver Post](https://cedclinic.com/cannabis-industry-consolidation-trends-patient-access/) Local news report on PharmaCann's facility closure and job cuts in Denver's cannabis market. [Learn more](https://cedclinic.com/cannabis-industry-consolidation-trends-patient-access/) Mass layoff as cannabis MSO PharmaCann exits Colorado market – MJBizDaily Industry analysis of PharmaCann's exit from Colorado and its implications for the cannabis market. Explore insights ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).